IDEAYA Biosciences Appoints Darrin Beaupre As Chief Medical Officer

RTTNews | vor 826 Tagen
IDEAYA Biosciences Appoints Darrin Beaupre As Chief Medical Officer

(RTTNews) - Oncology company IDEAYA Biosciences, Inc. (IDYA) announced that Darrin Beaupre has joined the company as its Chief Medical Officer, effective November 21, 2022.

Beaupre's extensive career includes various clinical development and translational research roles in industry, including most recently at BioSplice Therapeutics as Chief Medical Officer and Head of Research and Development in Oncology.

Beaupre previously served as Senior Vice President, Head of Early Oncology Development and Clinical Research at Pfizer, Inc., where he led cross-disciplinary groups including clinical development, clinical pharmacology, translational oncology and clinical operations related study clinicians.

Beaupre also served at Pharmacyclics (Abbvie) as Vice President, Head of Early Development and Immunotherapy, and at Amgen as Medical Director.

He was previously an Assistant Professor at the H. Lee Moffitt Cancer Center and Research Institute, and also held various earlier appointments at the University of Miami and the M.D. Anderson Cancer Center.

read more
IDEAYA Biosciences Q4 Results Misses Estimates

IDEAYA Biosciences Q4 Results Misses Estimates

IDEAYA Biosciences, Inc. (IDYA), a precision medicine oncology company, announced net loss of $32.64 million or $0.52 per share, wider than $23.07 million or $0.50 per share in the prior-year quarter.
RTTNews | vor 377 Tagen
IDEAYA Biosciences Says FDA Clears IND For Pol Theta Helicase Development Candidate GSK101

IDEAYA Biosciences Says FDA Clears IND For Pol Theta Helicase Development Candidate GSK101

Oncology company IDEAYA Biosciences, Inc. (IDYA) announced Monday the clearance of an Investigational New Drug (IND) application with the U.S. Food and Drug Administration (FDA) for initiation of a GSK-sponsored Phase 1/2 clinical trial to evaluate GSK101 (IDE705) for the treatment of patients having tumors with BRCA or other homologous recombination (HR) mutations or homologous recombination deficiency (HRD).
RTTNews | vor 560 Tagen
U.S. Construction Spending Unexpectedly Dips 0.2% In January

U.S. Construction Spending Unexpectedly Dips 0.2% In January

Construction spending in the U.S. unexpectedly edged modestly lower in the month of January, according to a report released by the Commerce Department on Monday. The Commerce Department said construction spending slipped by 0.2 percent to an annual rate of $2.193 trillion in January after climbing by 0.5 percent to a revised rate of $2.196 trillion in December.
RTTNews | vor 7Std 27 Minuten
U.S. Manufacturing Index Edges Lower But Still Indicates Modest Growth In February

U.S. Manufacturing Index Edges Lower But Still Indicates Modest Growth In February

A report released by the Institute for Supply Management on Monday showed its reading on U.S. manufacturing edged slightly lower in February, although the index still indicated growth in the sector for the second straight month. The ISM said its manufacturing PMI slipped to 50.3 in February after rising to 50.9 in January, but a reading above 50 still indicates growth.
RTTNews | vor 7Std 33 Minuten
Bay Street Likely To Open On Firm Note

Bay Street Likely To Open On Firm Note

Canadian shares are likely to open on a firm note Monday morning, tracking gains in European markets, and higher commodity prices. Worries about new tariffs by U.S. effective Tuesday could weigh and limit market's upside.
RTTNews | vor 9Std 11 Minuten
Eurozone Inflation Slows To 2.4%

Eurozone Inflation Slows To 2.4%

Eurozone inflation eased slightly in February partly reflecting the slowdown in services inflation but the rate remained above 2 percent, flash data from Eurostat showed on Monday. The harmonized index of consumer prices logged an annual growth of 2.4 percent after rising 2.5 percent in January. The rate was expected to ease to 2.3 percent.
RTTNews | vor 9Std 48 Minuten
UK Mortgage Lending Strongest Since 2022, Approvals Fall Slightly

UK Mortgage Lending Strongest Since 2022, Approvals Fall Slightly

Mortgage borrowing of British homebuyers hit the highest since September 2022, while home loan approvals decreased slightly in January ahead of the stamp duty changes in April, figures from the Bank of England showed on Monday. Mortgage lending increased GBP 0.9 billion to GBP 4.2 billion in January, which was the highest since September 2022.
RTTNews | vor 10Std 1 Minuten